Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VRCA

Verrica Pharmaceuticals Inc

May 22 • 04:00PM ET

6.06

+0.16 2.71 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: VYNE ARQT SPRO ADAG BDTX

| Held by: VXF VTI DFAS DFAC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.03	Insider Own	48.75%	Shs Outstand	17.18M	Perf Week	-3.35%
Market Cap	104.10M	Forward P/E	-	EPS next Y	-0.94	Insider Trans	102.38%	Shs Float	8.80M	Perf Month	-6.63%
Enterprise Value	84.94M	PEG	-	EPS next Q	-0.41	Inst Own	27.81%	Short Float	6.62%	Perf Quarter	8.02%
Income	-17.83M	P/S	2.80	EPS this Y	5.80%	Inst Trans	-5.29%	Short Ratio	5.48	Perf Half Y	35.27%
Sales	37.16M	P/B	6.48	EPS next Y	40.60%	ROA	-44.03%	Short Interest	0.58M	Perf YTD	-27.08%
Book/sh	0.93	P/C	5.05	EPS next 5Y	-	ROE	-240.35%	52W High	9.82 -38.30%	Perf Year	-2.26%
Cash/sh	1.20	P/FCF	-	EPS past 3/5Y	38.35% 37.12%	ROIC	-106.40%	52W Low	3.28 84.76%	Perf 3Y	-89.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	57.93% -	Gross Margin	89.52%	Volatility	9.92% 9.93%	Perf 5Y	-94.66%
Dividend TTM	-	EV/Sales	2.29	EPS Y/Y TTM	91.39%	Oper. Margin	-36.39%	ATR (14)	0.62	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.90	Sales Y/Y TTM	417.63%	Profit Margin	-47.97%	RSI (14)	45.08	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	2.02	EPS Q/Q	55.76%	SMA20	-10.44%	Beta	1.52	Target Price	16.50
Payout	-	Debt/Eq	0.09	Sales Q/Q	46.06%	SMA50	-0.86%	Rel Volume	0.68	Prev Close	5.90
Employees	76	LT Debt/Eq	0.04	Earnings	May 12 AMC	SMA200	2.48%	Avg Volume	106.15K	Price	6.06
IPO	Jun 15, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	0.84% 11.27%	Trades		Volume	71,894	Change	2.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)